연구동향 분석

왜 다양한 항우울제가 필요한가?

윤호경 김용구 2008년

논문상세정보
인용/피인용
' 왜 다양한 항우울제가 필요한가?' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 내과학
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
452 0

0.0%

' 왜 다양한 항우울제가 필요한가?' 의 참고문헌

  • Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment
    Am J Hum Genet 78 : 804 ~ 814 [2006]
  • Use of topiramate, a new anti-epileptic as a mood stabilizer
    J Affect Disord 50 : 245 ~ 251 [1998]
  • Two-year outcome of elderly patients with anxious depression
    Psychiatry Res 66 : 23 ~ 31 [1997]
  • The validity of major depression with atypical features based on a community study
    J Affect Disord 26 : 117 ~ 125 [1992]
  • The tachykinin NK1 receptor in the brain: pharmacology and putative functions
    Eur J Pharmacol 375 : 51 ~ 60 [1999]
  • The role of cytokines in depression and their therapeutic implication
    Korean J Psychopharmacol 11 : 304 ~ 312 [2000]
  • The role of cytokine network in psychological stress
    Acta Neuropsychiatrica 15 : 148 ~ 155 [2003]
  • The role of corticotropin-releasing factor in depression and anxiety disorders
    J Endocrinol 160 : 1 ~ 12 [1999]
  • The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety
    J Psychiatr Res 33 : 181 ~ 214 [1999]
  • The power of sample size and homogenous sampling: association between the 5-HTTLPR serotonin transporter polymorphism and major depressive disorder
    Biol Psychiatry 57 : 247 ~ 251 [2005]
  • The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs
    Mol Psychiatry 7 : 1107 ~ 1114 [2002]
  • The monocyte-T-lymphocyte hypothesis of major depression
    황보순 [1995]
  • The impact of early adverse experiences on brain systems involved in the pathophysiology of anxiety and affective disorders
    허균 [1999]
  • The immune system, depression and the action of antidepressants
    허 충 The immune system [2001]
  • The functioning and well-being of depressed patients. Results from the Medical Outcomes Study
    [1989]
  • The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)
    한상철 [2003]
  • The corticosteroid receptor hypothesis of depression
  • The clinical, psychosocial, and pharmacoeconomic ramifications of remission
  • The cellular neurobiology of depression
    최효진 [2001]
  • The catecholamine hypothesis of affective disorders: a review of supporting evidence
    최홍준 [1965]
  • Synaptic plasticity and mood disorders
    최보중 [2002]
  • Substance P antagonists: novel agents in the treatment of depression
    차유림 [2000]
  • Spectrum of activity of lamotrigine in treatmentrefractory bipolar disorder
    조윤경 [1999]
  • Sequence variations in CREB1 cosegregate with depressive disorders in women
    정은숙 [2003]
  • Selective blockade of neurokinin-2 receptors produces antidepressant- like effects associated with reduced corticotropin-releasing factor function
    정연수 [2001]
  • SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression
    조미경 [2004]
  • Roots I, Brockmoller J. A 40-basepair VNTR polymorphism in the dopamine transporter (DAT1) gene and the rapid response to antidepressant treatment
    정동윤 Roots I [2007]
  • Risk factors associated with the development of postpartum mood disorders
    전헌선 [2005]
  • Remission and relapse in major depression: a two-year prospective follow-up study
    장순미 [1995]
  • Regulation of the human serotonin transporter by interleukin-1 beta
    임용우 [1995]
  • Regulation of adult neurogenesis by psychotropic drugs and stress
    임안수 [2001]
  • Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression
  • Recent advances in the neurobiology of depression
    이희자 [2002]
  • Rapid reversal of psychotic depression using mifepristone
    이화진 [2001]
  • Pramipexole augmentation in the treatment of unipolar and bipolar depression: a retrospective chart review
    이영배 [2000]
  • Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment
  • Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders
    이선경 [1988]
  • Osanetant Sanofi-Synthelabo
    윤혜련 [2001]
  • On the role of metabotropic glutamate receptors in the mechanisms of action of antidepressants
    육근철 [2002]
  • New insights into the role of cortisol and the glucocorticoid receptor in severe depression
    오지영 [2002]
  • Neuroprotective properties of tianeptine: interactions with cytokines
    오영태 [2003]
  • Neuropeptide Y: anatomical distribution and possible function in mammalian nervous system
    오영순 [1986]
  • Neuropeptide Y (NPY) and depression: from animal studies to the human condition
    오영범 [2002]
  • Neurokinin receptor subtypes characterized by biological assays
    오소정 [1994]
  • Neuroimaging studies of mood disorders
    오소라 [2000]
  • Neurobiology of depression
    오선영 [2002]
  • Monoamine oxidase inhibitors. A review of antidepressant effectiveness
    양길석 [1979]
  • Loss-of-function mutation in tryptophan hydroxylase- 2 identified in unipolar major depression
    석임복 [2005]
  • Latent class analysis of lifetime depressive symptoms in the national comorbidity survey
  • Involvement of hippocampal neuropeptide Y in mediating the chronic actions of lithium, electroconvulsive stimulation and citalopram
    배재정 Involvement of hippocampal neuropeptide Y in mediating the chronic actions of lithium [2000]
  • Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
    박인기 [2003]
  • Inflammatory markers in major depression and melancholia
    박옥희 [2001]
  • Increase of bcl-2 protein in neuronal dendritic processes of cerebral cortex and hippocampus by the antiparkinsonian drugs, talipexole and pramipexole
    박승희 Increase of bcl-2 protein in neuronal dendritic processes of cerebral cortex and hippocampus by the antiparkinsonian drugs [2000]
  • Importance of psychiatric diagnosis in prediction of clinical drug effects
    박병기 [1967]
  • Glutamate and Depression: Clinical and Preclinical Studies
    나일주 [2003]
  • Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features
    김춘희 Fluoxetine [1994]
  • Factor study of the Hamilton Rating Scale for Depression and the Bech Melancholia Scale
    김정효 [1990]
  • Factor analytic study of depressive disorders
    김정효 [1989]
  • Evidence for a relationship between genetic variants at the brainderived neurotrophic factor (BDNF) locus and major depression
    김이순 [2005]
  • Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression
    김영연 Enhancing neuronal plasticity and cellular resilience to develop novel [2003]
  • Elucidating the antidepressant actions of substance P (NK1 receptor) antagonists
    김신자 [2002]
  • Electroconvulsive stimuli enhance both neuropeptide Y receptor Y1 and Y2 messenger RNA expression and levels of binding in the rat hippocampus
    김순희 [2000]
  • Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated
    김소진 [2000]
  • Effects of repeated stress on expression of corticotropin releasing factor type I and II receptors
    김세영 [2003]
  • Effects of gonadal steroids in women with a history of postpartum depression
    김선희 [2000]
  • Effects of early adverse experiences on brain structure and function: clinical implications
    김선정 [2000]
  • Does co-morbid depressive illness magnify the impact of chronic physical illness? A population-based perspective
    김경미 [2006]
  • Distinct mechanism for antidepressant activity by blockade of central substance Preceptors
  • Differential regulation of neuropeptide Y mRNA expression in the arcuate nucleus and locus coeruleus by stress and antidepressants
    권성호 [2000]
  • Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression
    국립국악원 Dexamethasone response [1997]
  • Depression, stress and the adrenal axis
    교육인적자원부 Depression [2003]
  • Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression
  • Cytokines and the brain:implications for clinicalpsychiatry
    교육과학기술부 Cytokines and the brain: implications for clinical psychiatry [2000]
  • Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6
    Cytokine-specific central monoamine alterations induced by interleukin-1 [1994]
  • Cytokine-serotonin interaction through IDO: A neurodegeneration hypothesis of depression
  • Current advances and trends in the treatment of depression
  • Cross-national epidemiology of major depression and bipolar disorder
    곽호완 [1996]
  • Course and recurrence of postnatal depression. Evidence for the specificity of the diagnostic concept
    곽대영 [1995]
  • Corticotropin-releasing hormone receptor subtypes and emotion
    공혜진 [1999]
  • Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gammahydroxybutyrate
    White Club drugs: methylenedioxymethamphetamine [2002]
  • Chronic antidepressant administration increases the expression of cAMP-specific phosphodiesterase 4A and 4B isoforms
  • Chronic administration of the non-peptide CRH type 1 receptor antagonist antalarmin does not blunt hypothalamicpituitary- adrenal axis responses to acute immobilization stress
    Unalmis [1999]
  • Children of currently depressed mothers: a STAR*D ancillary study
    Tunstall.J [2006]
  • CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors
    곽병선 CP-154 [1996]
  • Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication
    Rosenberg Atypical depression [1990]
  • Association between serotonin transporter gene promoter polymorphism and suicide: results of a meta-analysis
    Riggenbach [2004]
  • Anxious depression in elderly patients. Response to antidepressant treatment
    Pring [1997]
  • Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders
    Prince Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist [2002]
  • Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors
    Prince Anxiolytic and side-effect profile of LY354740: a potent [1998]
  • Antidepressant specificity in atypical depression
    Polya [1988]
  • Antidepressant effects of ketamine in depressed patients
    Polya [2000]
  • Alterations in cell adhesion molecule L1 and functionally related genes in major depression: a postmortem study
    Newell [2005]
  • Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms
    Meyer [2002]
  • A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: II. Suicidal behavior
    Mayer [2003]
  • A molecular and cellular theory of depression
    Lang [1997]
  • 3D MRI studies of neuroanatomic changes in unipolar major depression: the role of stress and medical comorbidity
    Jun [2000]